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We describe two cases of refractory ventricular fibrillation complicating transcatheter
interventional procedures. Extracorporeal membrane oxygenation was used in each to
support percutaneous coronary revascularization in the fibrillating heart as a means of
facilitating successful restoration of sinus rhythm. Cathet. Cardiovasc. Intervent. 48:402 –
405, 1999. r 1999 Wiley-Liss, Inc.
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INTRODUCTION
The use of cardiopulmonary bypass has allowed the
surgical treatment of congenital and acquired diseases of
the heart since 1954 [1]. Recently, portable cardiopulmo-
nary support (PCPB or CPS) has been used prophylacti-
cally to support high-risk percutaneous coronary interven-
tions and in angioplasty emergencies complicated by
cardiac failure [2–4]. The hematologic sequelae of conven-
tional CPS (hemolysis; loss of circulating volume, red
cells, and clotting factors; and the frequent need for blood
factor transfusion) typically restrict its use to less than
6 hr.
Extracorporeal membrane oxygenation (ECMO) is a
form of cardiopulmonary bypass that couples the use of
cardiopulmonary bypass machinery (mechanical pump,
oxygenator, heat exchanger, arterial and venous cannulae,
and tubing like that of CPS) with protocols and staff
devoted to the prolonged use of extracorporeal circula-
tory support. Originally used in newborns and children
with severe cardiac and respiratory failure [5,6] and later
for adult respiratory distress syndrome (ARDS) [7], it is
classically viewed as a bridge to definitive therapy or
disease resolution. The use of anticoagulation, fluid, and
hemodynamic management protocols by a dedicated staff
allows for the safe use of ECMO for weeks in the ICU.
This makes it an ideal support system for patients
expected to have prolonged recovery. While never tested
as a support strategy for high-risk percutaneous interven-
tions, the prolonged use of emergently instituted ECMO
for primary cardiac failure in the adult (both spontaneous
and in the setting of cardiac surgery) has been described
with varying degrees of success [8–10].
We describe two patients with refractory ventricular
fibrillation (VF), one complicating elective left anterior
descending (LAD) artery angioplasty and the other
complicating ventricular tachycardia (VT) catheter abla-
tion. Both required aggressive resuscitation, circulatory
support, and percutaneous revascularization in the fibril-




A 54-year-old man, who 9 years previously had
undergone coronary artery bypass grafting and carotid
endarterectomy, presented with worsening angina pecto-
ris and right lower extremity claudication. Pharmacologic
stress testing and peripheral and coronary angiography
showed impaired flow reserve in the anterior wall, severe
narrowing of the right internal iliac artery, left ventricular
ejection fraction of 40%, severe three-vessel coronary
a tery disease, patent vein grafts to the right coronary and
obtuse marginal arteries, and an occluded vein graft to the
LAD. The native LAD, with significant disease at the
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ostium and mid segments, was thought to be responsible
for his angina and appeared amenable to percutaneous
revascularization.
The decision was made to proceed with percutaneous
coronary angioplasty (3 15 mm NC Bandit, Scimed
Life Systems, Maple Grove, MN) of the ostial and mid
LAD lesions. This resulted in an improved but subopti-
mal lumen with no evidence of dissection. Soon thereaf-
ter, the patient developed ventricular fibrillation unrespon-
sive to removal of the guiding catheter from the left
coronary artery and immediate external defibrillation.
Aggressive external cardiac compression was performed
and endotracheal intubation established. Repeat angiogra-
phy showed ostial LAD occlusion with loss of wire
position from the distal artery. Resuscitative efforts were
resumed. Multiple attempts at external defibrillation with
360 Joules using a standard monophasic defibrillator and
an anteroposterior patch configuration proved ineffective
despite intravenous loading with lidocaine, bretyllium,
and amiodarone. Defibrillation was then successfully
performed by adding a second external monophasic
defibrillator with a sternum-to-apex configuration, and
delivering 720 Joules by simultaneous manual delivery.
Transient postconversion asystole was treated with right
ventricular pacing. Despite multiple successful defibrilla-
tions using 720 Joules, ventricular fibrillation repeatedly
recurred and sinus rhythm could not be maintained.
While prolonged CPR and advanced cardiac life support
measures maintained excellent perfusion pressure and
oxygenation, severe acidemia developed and only brief
episodes of organized ventricular tachycardia could be
achieved with high-energy shocks. The decision was
made to place femoral arterial and venous cannulae (21
and 23 Fr, respectively) for ECMO support.
The patient was successfully placed on circulatory
support after 45 min of CPR, but the electrical storm
continued unabated despite continued efforts and improve-
ments in hemodynamics and acid-base disturbance. Atten-
tion was then redirected to revascularization, approxi-
mately 1 hr after commencing cardiopulmonary
resuscitation. While the patient remained in ventricular
fibrillation, the proximal and mid LAD segments were
successfully dilated and stented with three 33 15 mm
Palmaz-Schatz stents (Johnson and Johnson Interven-
tional Systems, Warren, NJ). Thrombolysis in myocardial
infarction (TIMI) grade 3 flow was restored and no
residual stenosis was evident in the stented areas. On the
first attempt after revascularization, the patient was
successfully defibrillated with 720 Joules and returned to
sinus rhythm.
He was transferred to the coronary care unit and
supported with IV amiodarone, mechanical ventilation,
and ECMO. Intact brain function was evident from the
time of initial resuscitative efforts and the patient was
responding to commands by the time of his arrival in the
CCU. Surface echocardiography initially showed ‘‘stun-
ning’’ of the anterior wall with gradual improvement in
systolic function over the ensuing days. Before distal
perfusion could be established, the left leg became
ischemic and necrotic, requiring above-the-knee amputa-
tion. He was weaned from amiodarone and ECMO
support within 5 days. He suffered no further myocardial
ischemia or ventricular arrhythmias. A prolonged hospital
course was complicated by pneumonia and finally necro-
tizing pancreatitis, which developed 30 days postangio-
plasty. The patient died during his second exploratory
laparotomy.
Case 2
A60-year-old man with a history of ischemic cardiomy-
opathy (ejection fraction 25%), successful stenting of the
mid right coronary artery (RCA) 4 months previously,
heart failure, ventricular tachycardia (VT), implantable
cardioverter defibrillator (ICD) therapy, and recent
nonischemic adenosine thallium scan presented for VT
ablation because of frequent ICD discharges. During the
ablation procedure, he developed intractable VF refrac-
tory to multiple attempts at pharmacologic and electrical
defibrillation. Aggressive CPR was performed and ECMO
was instituted within 30 min using 23 Fr right femoral
vein and 21 Fr right femoral artery cannulae. VF persisted
and the patient underwent emergency coronary angiogra-
phy, which showed 20% left main disease, subtotal
narrowing of the proximal and mid LAD, 70% and 90%
stenoses of the first obtuse marginal artery, occlusion of
the second obtuse marginal artery, and interval occlusion
of the mid RCA at the site of the previous stent
implantation. There were left-to-right and right-to-right
collaterals.
Heparin and abciximab (ReoPro, Centocor BV, the
Netherlands) were given and the RCA occlusion was
crossed and dilated (3.0-mm Bandit), resulting in a 10%
residual diameter stenosis. The first obtuse marginal
artery was also successfully dilated with the same balloon
catheter. Immediately thereafter, the patient was success-
fully defibrillated with one 360-Joule shock.
With the preservation of brain, lung, and kidney but
continued poor cardiac function over the ensuing 3 days,
the patient was thought to be a suitable cardiac assist
device and heart transplant candidate. Accordingly, left
and right ventricular assist devices (HeartMate, Thermo-
Cardiosystems, Woburn, MA) were implanted and ECMO
discontinued. The patient was successfully extubated
after 10 days, was later weaned from right ventricular
support, remained on left ventricular support for 6
months, and then underwent successful orthotopic car-
diac transplantation. He is alive 9 months later.
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DISCUSSION
While percutaneous coronary interventions and inva-
sive electrophysiologic procedures are occasionally com-
plicated by ventricular fibrillation [11–13], these events
are rarely unresponsive to rapid electrical defibrillation.
Previously reported is the use of emergency cardiopulmo-
nary support to establish a more favorable milieu for
successful defibrillation (i.e., improved oxygenation, per-
fusion, and acid-base balance). In previous reports of
emergency bypass support [3,14–17], all patients with VF
were successfully converted to sinus rhythm with the
institution of CPS but prior to revascularization. The
patients described herein represent situations in which
extracorporeal support (and resultant corrections in hemo-
dynamic and acid-base disturbance) alone was insuffi-
cient for reestablishing sinus rhythm and dictated the
need for addressing the presumed ischemic etiology for
the refractory electrical storm. These two cases therefore
represent the first reports of percutaneous coronary
interventions in the fibrillating heart made possible by the
emergent institution of ECMO support. In case 1, efforts
at recanalization of the occluded artery could not be
achieved without prolonged periods of pulselessness and
brain anoxia. In case 2, it was assumed that only relief of
the ischemic burden would make defibrillation possible.
Given the options of intra-aortic balloon pumping, CPS,
or ECMO as ‘‘bailout’’ support measures, the latter was
chosen because of an anticipated need for prolonged
circulatory support (i.e., longer than the usual 6-hr
limitation with CPS). At our institution, ECMO support
can be achieved within minutes, especially in the cardiac
catheterization laboratory where arterial and venous
access is either already established or easily attained.
Once placed ‘‘on circuit,’’ patients are constantly moni-
tored by a team of physicians, nurses, and technicians
dedicated to the care of ECMO patients. This team
accounts for the ability to institute rapidly and continue
support for prolonged periods of time (sometimes up to
30 to 40 days).
Survival in the two patients described, despite pro-
longed ventricular fibrillation, stemmed from very effec-
tive initial external cardiac massage efforts, which al-
lowed the operators time to define the inciting problem
and begin circulatory support. In the first case, loss of
wire position during CPR precluded immediate recanali-
zation of the culprit vessel and dictated the need to
stabilize the patient by extracorporeal means. Multiple
attempts at defibrillation were unsuccessful in part be-
cause of an ischemic substrate and severe, uncorrectable
acidemia. In the second case, ECMO support allowed
time to transport the patient to the catheterization labora-
tory where revascularization could be performed. In both
cases, maintenance of sinus rhythm was achieved only
after successful revascularization was performed with the
heart still fibrillating.
The ECMO techniques, contrasted to those of CPS,
that contributed to the success in these patients were:
heparin anticoagulation by continuous infusion, titrated
to maintain whole blood activated clotting time (ACT) at
180 6 10 sec; venous drainage by siphon, rather than
suction, to eliminate hemolysis; the exclusion of reser-
voirs or stagnant areas within the circuit; platelet transfu-
sion to maintain platelet count greater than 100,000/mm3;
and a dedicated team of caregivers using protocols
designed for extended continuous perfusion in the ICU.
Our report demonstrates the first successful use of
extracorporeal membrane oxygenation-supported percuta-
neous coronary revascularization in the fibrillating heart.
Successful revascularization facilitated restoration of
sinus rhythm in what was otherwise refractory ventricular
fibrillation and represents dramatic evidence for an
ischemic substrate in intractable ventricular fibrillation.
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